Can a drug developed for sickle cell anemia mitigate lung damage in patients with COVID-19?
(SACRAMENTO) — Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19. Senicapoc study to assess whether drug can prevent SARS and lung damage and reduce days spent on a ventilator. Senicapoc study to assess whether drug can prevent SARS and lung damage and reduce days…